The FEMA GRAS assessment of lactones used as flavour ingredients

Food and Chemical Toxicology

Volumn 36, Issue 4, 1998, Pages 249-278

  Adams, T B ^a   Greer, D B ^a   Doull, J ^c   Munro, I C ^c   Newberne, P ^c   Portoghese, P S ^c   Smith, R L ^c   Wagner, B M ^c   Weil, C S ^c   Woods, L A ^c   Ford, R A ^b  

^a Flavor Extract Manufacturers' Assoc   (United States)

^b RESEARCH INSTITUTE FOR FRAGRANCE MATERIALS   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLAVORING AGENT; GAMMA BUTYROLACTONE; LACTONE;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOASSAY; CARCINOGENICITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; FOOD COMPOSITION; GENETIC TOXICOLOGY; GENOTOXICITY; KIDNEY DISEASE; KIDNEY TUMOR; LD 50; LIVER TUMOR; MOUSE; NONHUMAN; REVIEW; THIN LAYER CHROMATOGRAPHY; TOXICITY;

ANIMALIA;

EID: 0032489789     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(97)00163-4     Document Type: Article

References (181)

1. Aeschbacher H. U., Wolleb U., Loliger J., Spadone J. C. and Liardon R. (1989) Contribution of coffee aroma substituents to the mutagenicity of coffee. Food and Chemical Toxicology 27, 227-232.
2. 50 test on substance 2-3867. Unpublished report to RIFM.
3. Albro P. W. (1975) The metabolism of 2-ethyl-1-hexanol in rats. Xenobiotica 5, 625-636.
4. Arena C. and Fung H. L. (1980) Absorption of sodium γ-hydroxybutyric acid and its prodrug γ-butyrolactone: relationship between in vitro transport and in vivo absorption. Journal of Pharmaceutical Sciences 69, 356-358.
5. Ashby J. and Tenant R. W. (1991) Prediction of rodent carcinogenicity for 44 chemicals: Results. Mutagenesis 9, 7-15.
6. Baker R. S. U. and Bonin A. M. (1981) Study of 42 coded compounds with the Salmonella/mammalian microsome assay. Progress in Mutation Research 1, 249-260.
7. Bar V. F. and Griepentrog F. (1967) Where we stand concerning the evaluation of flavouring substances from the viewpoint of health. Medizin Ernahrung 8, 244-251.
8. BASF (1976) Acute toxicity studies on octahydrocoumarin. Unpublished report to RIFM.
9. Bessman S. P. and Fishbein W. N. (1963) Gamma-hydroxybutyrate, a normal brain metabolite. Nature 200, 1207-1208.
10. Bessman S. P., Rosen J. and Layne E. C. (1953) γ-Aminobutyric-glutamic acid transamination in brain. Journal of Biological Chemistry 201, 385-391.
11. Bioassay Systems Corporation (1984) Single dose oral toxicity tests. Study number 84-302. Unpublished report to RIFM.
12. Boncinelli A., Pranoi G., Greggia A. and Casalgrandi L. (1971) Preliminary trial of sodium γ-hydroxybutyrate in Parkinson's disease. Rivista di Farmacologia e Terepia 11, 29-32.
13. Boyland E. and Chasseaud L. (1970) The effect of carbonyl compounds on rat liver glutathione levels. Biochemical Pharmacology 19, 1528-1533.
14. Brewster D., Jones R. S. and Parke D. V. (1977a) The metabolism of cyclohexanecarboxylic acid in the rat. Biochemical Journal 164, 595-600.
15. Brewster D., Jones R. S. and Parke D. V. (1977b) The metabolism of cyclohexanecarboxylic acid in the isolated perfused rat liver. Xenobiotica 7, 601-609.
16. Brooks T. M. and Dean B. J. (1981) Mutagenic activity of 42 coded compounds in the Salmonella/microsome assay with preincubation. Progress in Mutation Research 1, 261-270.
17. Brusick D. (1986) Genotoxic effects of cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environmental Mutagenesis 8, 879-886.
18. Buch S. A. (1981) Acute oral toxicity of cyclohexyl lactone in the rat. Unpublished report to RIFM.
19. Burdock G. A., Wagner B. M., Smith R. L., Munro I. C. and Newberne P. M. (1990) 15. GRAS substances. Food Technology 44, 78-86.
20. Chasseaud L. (1979) GSH conjugation with carcinogens. Advances in Cancer Research 29, 230.
21. Cholerton S., Idle M. E., Vas A., Gonzalez F. J. and Idle J. R. (1992) Comparison of a novel thin-layer chromatographic-nuorescence detection method with a spectronuorimetric method for the determination of 7-hydroxycoumarin in human urine. Journal of Chromatography 575, 325-330.
22. CIVO-TNO. (1994) Volatile components in food. Supplement 5 to the 6th Edition. Edited by H. Maarse, C. A. Visscher, L. C. Willemsens, L. M. Nijssen and M. H. Boelens. TNO Nutrition and Food Research, Zeist, The Netherlands. .
23. Cohen A. J. (1979) Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food and Cosmetics Toxicology 17, 277-289.
24. 50) of dehydromenthofurolactone in the rat. Unpublished report to RIFM.
25. 50) menthofurolactone in the rat. Unpublished report to RIFM.
26. Cox G. E., Bailey D. E. and Morgareidge K. (1974) 90-Day feeding study in rats with 5-hydroxy-2,4-decadienoic acid δ-lactone. Unpublished report to RIFM.
27. Culp H. W. and McMahon R. E. (1968) Reductase for aromatic aldehydes and ketones. Partial purification and properties of a reduced triphosphopyridine nucleotide dependent reductase from rabbit kidney cortex. Journal of Biological Chemistry 243, 848-852.
28. Dambly C., Thoman Z. and Radman M. (1981) Cell transformation test with baby hamster kidney cells. Progress in Mutation Research 1, 626-637.
29. Deichmann W., Hirose B. R. and Witherup S. (1945) Observations on the effect of γ-valerolactone upon experimental animals. Journal of Industrial Hygiene and Toxicology 27, 263-268.
30. Deisinger P. J., Boatman R. J. and Guest D. (1994) Metabolism of 2-ethylhexanol administered orally and dermally to the female Fischer 344 rat. Xenobiotica 24, 429-440.
31. Deuel H. J. (1957) The Lipids, Their Chemistry and Biochemistry, Vol. III. Wiley Interscience, New York.
32. Dickens F. and Jones H. E. (1965) Further studies on the carcinogenic action of certain lactones and related substances in the rat and mouse. British Journal of Cancer 9, 392-403.
33. Diliberto J. J., Srinivas P., Overstreet D., Usha G., Burka L. T. and Birnbaum L. S. (1990) Metabolism of citral, an α, β-unsaturated aldehyde, in male F344 rats. Drug Metabolism and Disposition 18, 866-875.
34. 14C] butyrate by rat brain: relationship to the Krebs cycle and metabolic compartmentation of amino acids. Journal of Neurochemistry 30, 1305-1309.
35. Edwards K. B. (1970) Acute toxicity evaluation. Unpublished report to RIFM.
36. Egan D., O'Kennedy R., Moran E., Cox D., Prossier E. and Thorne R. D. (1990) The pharmacology, metabolism, analysis and applications of coumarin and coumarin-related compounds. Drug Metabolism Reviews 22, 503-529.
37. Emberger R. (1994) Hydrolysis of whiskey lactone. Unpublished report to RIFM.
38. Engel K-H., Heidlas J., Albrecht W. and Tressl R. (1989) Biosynthesis of chiral flavours and aroma compounds in plants and microorganisms. In Flavour Chemistry, Trends and Developments. Edited by R. Teranishi, R. Buttery and F. Shahidi. ACS Symposium Series 388. American Chemical Society, Washington, DC.
39. Environmental Protection Agency (1991) Risk Assessment Forum. Alpha 2μ-globulin association with chemically induced renal toxicity and neoplasia in the male rat. Publication No. EPA/625/3-91019F.
40. Fassett D. (1961). Unpublished report to RIFM.
41. Felsted R. L. and Bachur N. R. (1980) Ketone reductases. In Enzymatic Basis of Detoxification. Edited by W. Jakoby. Vol. I, pp. 281-293. Academic Press, New York.
42. Fentem J. H. and Fry J. R. (1992) Metabolism of coumarin by rat, gerbil and human liver microsomes. Xenobiotica 22, 357-367.
43. Ferrara S. D., Zotti S., Tedeschi L., Frison G., Castagna F., Gallimberti L., Gessa G. L. and Palantini P. (1992) Pharmacokinetics of γ-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. British Journal of Clinical Pharmacology 34, 231-235.
44. Feuer G. (1974) The metabolism and biological actions of coumarins. In Progress Medicinal Chemistry. Edited by G. P. Ellis and G. B. West. Vol. 10, pp. 85-158. Elsevier, Amsterdam.
45. Fey E. G., White H. A. and Rabin B. R. (1981) Development of the degranulation test system. Progress in Mutation Research 1, 236-244.
46. Fishbein W. N. and Bessman S. P. (1964) γ-Hydroxybutyrate in mammalian brain. Journal of Biological Chemistry 239, 357-361.
47. Fishbein W. N. and Bessman S. P. (1966) Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing the formation and hydrolysis of γ-lactones. I. Tissue location, stoichiometry, specificity, distinction from esterase. Journal of Biological Chemistry 241, 4835-4841.
48. FDA (1993) Priority-based assessment of food additives (PAFA) database. Center for food safety and applied nutrition, 58. Food and Drug Administration, Washington, DC.
49. Forrester L. M., Henderson C. J., Glancey M. J., Back D. J., Park B. K., Ball S. E., Kitteringham N. R., McLaren A. W., Miles J. S., Skett P. and Wolf C. R. (1992) Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal 281, 359-368.
50. Foureman P., Mason J. M., Valencia R. and Zimmering S. (1994) Chemical mutagenesis testing in Drosophila. X. Results of 70 coded chemicals tested for the National Toxicology Program. Environmental and Molecular Mutagenesis 23, 208-227.
51. Freifeld M. and Hort E. V. (1966) Glycols: 1,4-butylene glycol and gamma-butyrolactone. Kirk-Othmer Encyc. Chem. Technol. 2nd Ed 10, 667-676.
52. Fujita H. and Sasaki M. (1987) Mutagenicity test of food additives with salmonella typhimurium TA97 and TA102. II. Annual Report of the Tokyo Metropolitan Research Laboratory of Public Health 38, 423-430.
53. Furuya T. (1958) Studies on the metabolism of the naturally occurring coumarins. V. Urinary metabolites of coumarin and dihydrocoumarin. Chemical and Pharmaceutical Bulletin 6, 701-706.
54. Galea V., Zugravu E., Suciu D. and Buraga S. (1965) Toxicity of C14-C20 aldehydes. Igiena 14, 203-208.
55. Garner R., Welch A. and Pickering C. (1981) Mutagenic activity of 42 coded compounds in the salmonella/ microsome assay. Progress in Mutation Research 1, 280-284.
56. Guidotti A. and Ballotti P. L. (1970) Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate. Biochemical Pharmacology 19, 884-894.
57. Hagan E. C., Hansen W. H., Fitzhugh O. G., Jenner P. M., Jones W. I., Taylor J. M., Long E. L., Nelson A. M. and Brouwer J. B. (1967) Food flavourings and compounds of related structure. II. Subacute and chronic toxicity. Food and Cosmetics Toxicology 5, 141-157.
58. Hampel H. and Hapke H. J. (1968) Pharmacology of gamma-butyrolactone. Archives of International Pharmacodynamics and Therapeutics 171, 306-322.
59. Haworth S., Lawlor T., Mortelmans K., Speck W. and Zeigler E. (1983) Salmonella mutagenicity test results for 250 chemicals. Environmental Mutagens 5, 3-142.
60. Hayashi M., Kishi M., Sofuni T. and Ishidate M., Jr (1988) Micronucleus test in mice on 39 food additives and eight miscellaneous chemicals. Food and Chemical Toxicology 26, 487-500.
61. Heck J. D., Vollmuth T. A., Cifone M. A., Jagannath D. R., Myhr B. and Curren R. D. (1989) An evaluation of food flavouring ingredients in a genetic toxicity screening battery. Toxicologist 9, 257.
62. Hubbard S. A., Green M. H. L., Bridges B. A., Wain A. J. and Bridges J. W. (1981) Fluctuation test with S9 and hepatocyte activation. Progress in Mutation Research 1, 361-370.
63. Hunter A. S., Long W. J. and Ryrie C. G. (1971) An evaluation of gamma-hydroxybutyric acid in pediatric practice. British Journal of Anaesthesiology 43, 620-627.
64. Huwer T., Altmann H-J., Grunow W., Lenhardt S., Przybylski M. and Eisenbrand G. (1991) Coumarin mercapturic acid isolated from rat urine indicates metabolic formation of coumarin 3,4-epoxide. Chemical Research in Toxicology 4, 586-590.
65. Ichinotsubo D., Mower H. and Mandel M. (1981) Mutagen testing of a series of paired compounds with the Ames Salmonella testing system. Progress in Mutation Research 1, 298-301.
66. Ishidate M., Sofuni T., Yoshikawa K., Hayashi M., Nohmi T., Sawada M. and Matsuoka A. (1984) Primary mutagenicity screening of food additives currently used in Japan. Food and Chemical Toxicology 22, 623-636.
67. Jakoby W. B. and Scott E. M. (1959) Aldehyde oxidation. III. Succinic semialdehyde dehydrogenase. Journal of Biological Chemistry 234, 937-940.
68. Jenner P. M., Hagan E. C., Taylor J. M., Cook E. L. and Fitzhugh O. G. (1964) Food flavourings and compounds of related structure I. Acute oral toxicity. Food and Cosmetics Toxicology 2, 327-343.
69. Kassinova G. V., Kavaltsova S. V., Marfin S. V. and Zakhrov I. A. (1981) Activity of 40 coded compounds in differential inhibition and mitotic crossing-over assays in yeast. Progress in Mutation Research 1, 434-455.
70. Katz M., Heddle J. A. and Salamone M. F. (1981) Mutagenic activity of polycyclic aromatic hydrocarbons and other environmental pollutants. In Polynuclear Aromatic Hydrocarbons-Polynuclear Aromatic Hydrocarbons. Edited by M. Cooke and A. J. Dennis, pp. 519. Battelle Press, Columbus, OH.
71. Kawachi T., Komatsu T., Kada T., Ishidate M., Sasaki T., Sugiyama T. and Tazima Y. (1981) Results of recent studies on the relevance of various short-term screening tests in Japan. Applied Methods in Oncology 3, 253-267.
72. Killenberg P. G. and Webster L. T. Jr (1980) Conjugation by peptide bond formation. In Enzymatic Basis of Detoxification. Edited by W. Jakoby. Vol. II, pp. 141-164. Academic Press, New York.
73. Kuroda K., Tanaka S., Yu Y. S. and Ishibashi T. (1984) Rec-assay of food additives. Nippon Kosnu Eisei Zasshi 31, 277-281.
74. Laborit H., Jouany J. M., Gerard J. and Fabiani F. (1960) Sur un substrat metabolique a action centrale inhibitrice. Le 4-hydroxybutyrate de Na. Pressé Medicale 50, 1867-1869.
75. Lake B. G., Evans J. G., Lewis D. F. V. and Price R. J. (1994) Comparison of the hepatic effects of coumarin, 3,4-dimethylcoumarin, dihydrocoumarin and 6-methylcoumarin in the rat. Food and Chemical Toxicology 32, 743-751.
76. Lake B. G., Gray T. J. B., Evans J. G., Lewis D. F. V., Beamand J. A. and Hue K. L. (1989) Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: Comparison with dihydrocoumarin and other coumarin metabolites. Toxicology and Applied Pharmacology 97, 311-323.
77. Lake B. G. and Lewis D. F. V. (1993) Structure-activity relationships for chemically produced peroxisome proliferation in mammalian liver. In Peroxisomes. Biology and Importance in Toxicology and Medicine. Edited by G. Gibson and B. Lake. pp. 313. Taylor & Francis, London.
78. Lawrence D. V. (1991) The flavouring of confectionery. In Food Flavourings. Edited by P. R. Ashurst. AVI, New York.
79. Lee C. R. (1977) Evidence for the β-oxidation of orally administered γ-butyrolactone in humans. Biochemistry and Medicine 17, 284-291.
80. Lettieri J. T. and Fung H. L. (1978) Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium g-hydroxybutyrate and butyrolactone. Research Communications in Chemical Pathology and Pharmacology 22, 107-118.
81. Levenstein I. (1953). Unpublished report to RIFM.
82. Levenstein I. (1974). Unpublished report to RIFM.
83. Levenstein I. (1975). Unpublished report to RIFM.
84. Lewis C. A. and Palanker A. L. (1979). Unpublished report to RIFM.
85. Lewis D. F. V., Lake B. L., Ioannides C. and Parke D. V. (1994) Inhibition of rat hepatic aryl hydrocarbon hydrolase activity by a series of 7-hydroxycoumarins: QSAR studies. Xenobiotica 24, 829-838.
86. Lock E. A., Mitchell A. M. and Elcombe C. R. (1989) Biochemical mechanisms on induction of hepatic peroxisomes proliferation. Annual Review of Pharmacology and Toxicology 29, 145-163.
87. Loquet C., Toussaint G. and LeTalear J. Y. (1981) Studies on the mutagenic constituents of apple brandy and various alcoholic beverages collected in western France, a high incidence area for oesophageal cancer. Mutation Research 88, 155-164.
88. MacDonald D. J. (1981) Salmonella/microsome tests on 42 coded chemicals. Progress in Mutation Research 1, 285-297.
89. Madyastha K. M. and Raj C. P. (1993) Studies on the metabolism of a monoterpene ketone, R-(+)-pulegone - a hepatotoxin in rat: isolation and characterization of new metabolites. Xenobiotica 23, 509-518.
90. Mamelak M., Scharf M. B. and Woods M. (1986) Treatment of narcolepsy with gamma-hydroxybutyrate: A review of clinical and sleep laboratory findings. Sleep 9, 285-289; cited in Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gallimberti L, Gessa GL, Palantini P. (1992) Pharmacokinetics of γ-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. British Journal of Clinical Pharmacology 34, 231-235.
91. Mamelak M., Scharf M. B. and Woods M. (1986) Treatment of narcolepsy with gamma-hydroxybutyrate: A review of clinical and sleep laboratory findings. Sleep 9, 285-289; cited in Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gallimberti L, Gessa GL, Palantini P. (1992) Pharmacokinetics of γ-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. British Journal of Clinical Pharmacology 34, 231-235.
92. Maronpot R. R. and Boorman G. A. (1982) Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicologic Pathology 10, 71-80.
93. 1 mice: The National Toxicology Program, experience and position. Archives of Toxicology Suppl. 10, 10-26.
94. Martin C. N. and McDermid A. C. (1981) Testing of 42 coded compounds for their ability to induce unscheduled DNA repair synthesis in HeLa Cells. Progress in Mutation Research 1, 533-537.
95. Miles J. S., McClaren A. W., Forrester L. M., Glancey M. J., Lang M. A. and Wolf C. R. (1990) Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal 267, 365-371.
96. Möhler H., Patel A. J. and Balázs R. (1976) Gamma-hydroxybutyrate degradation in the brain in vivo: Negligible direct conversion to GABA. Journal of Neurochemistry 27, 253-258.
97. Moran E. J., Easterday O. D. and Oser B. L. (1980) Acute oral toxicity of selected flavour chemicals. Drug and Chemical Toxicology 3, 249-258.
98. Moreno O. M. (1972). Unpublished report to RIFM.
99. Moreno O. M. (1973). Unpublished report to RIFM.
100. Moreno O. M. (1974). Unpublished report to RIFM.
101. Moreno O. M. (1975a). Unpublished report to RIFM.
102. Moreno O. M. (1975b). Unpublished report to RIFM.
103. Moreno O. M. (1976). Unpublished report to RIFM.
104. Moreno O. M. (1977). Unpublished report to RIFM.
105. Moreno O. M. (1978). Unpublished report to RIFM.
106. Moreno O. M. (1980). Unpublished report to RIFM.
107. Morgareidge K. (1962) Food and Drug Research Laboratories (FDRL). Unpublished report to RIFM.
108. Morgareidge K. (1963) Food and Drug Research Laboratories (FDRL). Unpublished report to RIFM.
109. Mosandl A., Hagenauer-Hener U., Lehmann D., Kreis P. and Schmarr H-G. (1990) Chirality evaluation in flavour analysis. In Flavour Science and Technology. Edited by A. Bessiere and A. F. Thomas, pp. 21. John Wiley & Sons, New York, NY.
110. Munday R. and Kirkby W. W. (1971) Biological evaluation of a flavour cocktail. 2. 13-Week study in rats. Research Report PCW 71 1624.
111. Munday R. and Kirkby W. W. (1973) Biological evaluation of a flavour cocktail. 3. One-year feeding study in rats. Research Report PCW 73 1103.
112. Nagao M. and Takahashi Y. (1981) Mutagenic activity of 42 coded compounds in the salmonella/microsome assay. Progress in Mutation Research 1, 302-313.
113. National Academy of Sciences (NAS) (1970, 1975, 1982, 1987) Evaluating the safety of food chemicals. Washington, DC.
114. National Academy of Sciences (NAS) (1982) Evaluating the safety of food chemicals. Washington, DC.
115. National Academy of Sciences (NAS) (1987) Evaluating the safety of food chemicals. Washington, DC.
116. 1 mice (gavage studies).
117. National Toxicology Program (NTP) (1993a). Toxicology and carcinogenesis studies of 3,4-dihydrocoumarin in F344/N rats and B6C3F1 mice (gavage studies). NTP-TR-423; NIH Publication No. 93-3154. Research Triangle Park, NC.
118. 1 mice (gavage studies). NTP-TR-394; NIH Publication No. 93-2849. Research Triangle Park, NC.
119. Nutley P. B., Farmer P. and Caldwell J. (1994) Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose. Food and Chemical Toxicology 32, 877-886.
120. Oda Y., Hamono Y., Inoue K., Yamamoto H., Niihara T. and Kunita N. (1978) Mutagenicity of food flavours in bacteria. Shokuhin Eisei Hen 9, 177-181.
121. Oser B. L. (1962). Unpublished report to RIFM.
122. Oser B. L. (1963). Unpublished report to RIFM.
123. Oser B. L., Carson S. and Oser M. (1965) Toxicological tests on flavouring matters. Food and Cosmetics Toxicology 3, 563-569.
124. Paynter H. (1957). Unpublished report to RIFM.
125. Pearce R., Greenway D. and Parkinson A. (1992) Species differences and interindividual variation in the level of cytochrome P-450 2A enzymes: effects of coumarin, dicumarol and testosterone oxidation. Archives of Biochemistry and Biophysics 298, 211-225.
126. Pellmont I. (1970). Unpublished report to RIFM.
127. 14C]coumarin by rat hepatic microsomes. Xenobiotica 21, 499-514.
128. Piccirillo V. J. and Hartman W. C. (1980) Range-finding oral LD50 determination in rats with 5-hydroxy-2,4-decadienoic acid δ-lactone. Unpublished report to RIFM.
129. Ponnock K. S. (1992) A 14-dat toxicity study in rats with delta-2-dodecenolactone natural. Unpublished report to RIFM.
130. Posternak J. M. (1965). Unpublished report to RIFM.
131. Posternak J. M., Linder A. and Vodez C. A. (1969) Summaries of toxicological data. Food and Cosmetics Toxicology 7, 405-407.
132. Pollitt R. J. (1974) Phenylpropionic acid in the urine of patients with phenylketonuria and normals. Clinica Chimica Acta 55, 317-322.
133. Prival M. J., Sheldon A. T., Jr and Popkin D. (1982) Evaluation, using Salmonella typhimurium, of the mutagenicity of seven chemicals found in cosmetics. Food and Chemical Toxicology 20, 427-432.
134. Rautio A., Kraul H., Kojo A., Salmela E. and Pelkonen O. (1992) Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2, 227-233.
135. Reagan E. L. and Becci P. J. (1984) Acute oral LD50 study of massoia bark essential oil in Sprague-Dawley rats. Unpublished report to RIFM.
136. Richold M. and Jones E. (1981) Mutagenic activity of 42 coded compounds in the Salmonella/microsome assay. Progress in Mutation Research 1, 314-322.
137. Ritschel W. A., Brady M. E., Tan H. S. I., Hoffmann K. A., Yui I. M. and Grummich K. W. (1977) Pharmacokinetics of coumarin and its 7-hydroxymetabolites upon intravenous and peroral administration of coumarin in man. European Journal of Clinical Pharmacology 123, 457-461.
138. Roe F. J. C. and Baer A. (1985) Enzootic and epizootic adrenal medullary proliferative disease of rats: Influence of dietary factors which affect calcium absorption. Human Toxicology 4, 27-52.
139. Rosenkranz H. S., Hyman J. and Leifer Z. (1981) DNA polymerase deficient assay. Progress in Mutation Research 1, 210-218.
140. Roth R. H., Doherty J. D. and Walters J. R. (1980) Gamma-hydroxybutyrate: A role in the regulation of central dopaminergic neurons? Brain Research 189, 556-560.
141. Roth R. H. and Giarman N. J. (1965) Preliminary report on the metabolism of γ-butyrolactone and γ-hydroxybutyric acid. Biochemical Pharmacology 14, 177-178.
142. Roth R. H. and Giarman N. J. (1966) γ-Butyrolactone and γ-hydroxybutyric acid-I. Distribution and metabolism. Biochemical Pharmacology 15, 1333-1348.
143. Roth R. H. and Giarman N. J. (1969) Conversion in vivo of γ-aminobutyric to γ-hydroxybutyric acid in the rat. Biochemical Pharmacology 18, 247-250.
144. Roubier C. (1991). Unpublished report to RIFM.
145. Rowland I. and Severn B. (1981) Mutagenicity of carcinogens and noncarcinogens in the Salmonella/microsome test. Progress in Mutation Research 1, 323-332.
146. Samuelson O. B., Brenna J., Solheim E. and Scheline R. R. (1986) Metabolism of the cinnamon substituent o-methoxycinnamaldehyde in the rat. Xenobiotica 16, 845-852.
147. Schafer E. W. and Bowles W. A. (1985) The acute oral toxicity and repellency of 933 chemicals to house and deer mice. Archives of Environmental Contamination and Toxicology 14, 111-129.
148. Scheline R. R. (1968) Studies on the role of the intestinal micronora in the metabolism of coumarin in rats. Acta Pharmacologica et Toxicologica 26, 325-331.
149. Sharp D. C. and Parry J. M. (1981) Induction of mitotic gene conversion by 41 compounds using the yeast culture JD1. Progress in Mutation Research 1, 491-501.
150. Shellenberger R. (1971) Gulf South Research Institute. Unpublished report to RIFM.
151. Shellenberger R. (1973) Gulf South Research Institute. Unpublished report to RIFM.
152. Shilling W. H., Crampton R. F. and Longland R. C. (1969) Metabolism of coumarin in man. Nature 221, 664-665.
153. Simmon V. F. and Shepard G. F. (1981) Mutagenic activity 42 coded compounds in the Salmonella/microsome assay. Progress in Mutation Research 1, 333-342.
154. Smyth H. F., Jr, Carpenter C. P., Weil C. S., Pozzani U. C., Striegel J. A. and Nycum J. S. (1969) Range-finding toxicity data: List VII. American Industrial Hygiene Association Journal 30, 470-476.
155. Snead O. C., III Furner R. and Liu C. C. (1989) In vivo conversion of (-aminobutyric acid and 1,4-butanediol to γ-hydroxybutyric acid in rat brain. Biochemical Pharmacology 38, 4375-4380.
156. Styles J. A. (1981) Activity of 42 coded compounds in the BHK-21 Cell transformation tests. Progress in Mutation Research 1, 638-646.
157. Stofberg J. and Grundschober F. (1987) Consumption ratio and food predominance of flavouring materials. Perfumer and Flavourist 12, 27.
158. Stofberg J. and Kirschman J. C. (1985) The consumption ratio of flavouring materials: A mechanism for setting priorities for safety evaluation. Food and Chemical Toxicology 23, 857-860.
159. Symington T. (1969) Funtional Pathology of the Human Adrenal Gland. E & S Livingstone, London.
160. Tarloff J. B. and Goldstein R. S. (1994) Biochemical mechanisms of renal toxicity. In Biochemical Toxicology. Edited by E. Hodgson and P. Levi. 2nd Ed. Appleton and Lange, Norwalk, CN.
161. Tischer R. G., Fellers C. R. and Doyle B. J. (1942) The non-toxicity of levulinic acid. Journal of the American Pharmaceutical Association 31, 217-220.
162. Topham J. C. (1981) Evaluation of some chemicals by the sperm morphology assay. Progress in Mutation Research 1, 718-720.
163. Trubeck Labs (1957) Toxicological screening of components of food flavours. Dihydrocoumarin (benzodihydropyrone). Unpublished report.
164. Trueman R. W. (1981) Activity of 42 coded compounds in the Salmonella reverse mutation test. Progress in Mutation Research 1, 343-350.
165. van Iersel M., Henderson C. J., Walters D. G., Price R. J., Wolf C. R. and Lake B. G. (1994) Metabolism of [3-(14)C] coumarin by human liver microsomes. Xenobiotica 24, 795-803.
166. Venitt S. and Crofton-Sleigh C. (1981) Mutagenicity of 42 coded compounds in a bacterial assay using Escherichia coli and Salmonella typhimurium. Progress in Mutation Research 1, 351-360.
167. Voet D. and Voet J. G. (1990) Biochemistry. John Wiley & Sons, New York.
168. Voss K. A., Biesemeier J. A. and Thompson S. W. (1985) 90-Day dietary toxicity study of dehydromenthofurolactone in Sprague-Dawley rats. Unpublished report to RIFM.
169. Walkenstein S. S., Wiser R., Gudmundsen C. and Kimmel H. (1964) Metabolism of γ-hydroxybutyric acid. Biochimica et Biophysica Acta 85, 640-642.
170. 14C]coumarin in baboons. Food and Cosmetics Toxicology 19, 1-6.
171. Watanabe S. and Kinosaki A. (1990) Acute oral toxicity study of cis-6-dodecen-4-olide in the rat. Unpublished report to RIFM.
172. White S. and White G. (1991) Dairy flavourings. In Food Flavourings. Edited by P. R. Ashurst. AVI, New York.
173. Williams R. T. (1959) Detoxication Mechanisms, 2nd Ed., pp. 88-113. Chapman and Hall, London.
174. Wilson F. (1961a) Biological investigation of lactones as flavouring agents for margarine. Unpublished Report to RIFM.
175. Wilson F. (1961b) Biological investigation of "460" flavour mixture as flavouring agents for margarine. Unpublished report to RIFM.
176. Wohl A. (1974). Unpublished report to RIFM.
177. Yamano S., Tatsuno J. and Gonzalez F. J. (1990) The CYP2A3 gene product catalyses coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29, 1322-1329.
178. Yamazaki H., Inui I., Yun C. H., Guengerich F. P. and Shimada T. (1992) Cytochrome P-4502E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789-1794.
179. Yingnian Y., Yifab D., Ming F. and Xingruo C. (1990) ADPRT-mediated decrease of cellular NAD content and the detection of chemically induced DNA damage-development of a new short-term screening test for mutagens. Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College 5, 19-24.
180. Yoo Y. S. (1986) Mutagenic and antimutagenic activities of flavouring agents used in foodstuffs. Journal of the Osaka City Medical Center 34, 267-288.
181. Zlatkis A. and Liebich H. M. (1971) Profile of volatile metabolites in human urine. Clinical Chemistry 17, 592-594.